Indian Specialty Chemicals To Benefit From China+1 Strategy: Motilal Oswal
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
The Indian specialty chemicals sector has not benefited from the China+1 strategy, with none of our coverage companies showing any significant rise in exports (as a percentage of revenue) in the past decade.
On a consolidated basis, while exports from India have risen by ~50% over the past decade, other countries like Vietnam have shown a significant rise in exports.
Indian specialty companies will stand to benefit only when India takes concrete steps towards capitalising this new opportunity.
The consolidation in chemical companies still continues in China and is expected to result in a growing call for alternate suppliers of key chemicals.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.